Stay updated on GB001 in Adult Subjects With Moderate to Severe Asthma Clinical Trial

Sign up to get notified when there's something new on the GB001 in Adult Subjects With Moderate to Severe Asthma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GB001 in Adult Subjects With Moderate to Severe Asthma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T23:25:03.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update in the efficacy or safety evaluation of GB001 as maintenance therapy in adults with moderate to severe asthma. This change may reflect new data or findings related to the treatment of asthma in the clinical trial setting.
    Difference
    0.1%
    Check dated 2024-06-06T14:44:50.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participation in the study, specifying that participants must have a diagnosis of asthma and meet certain health conditions and treatment requirements. Previously, no information was provided about the participation criteria for collaborators and investigators.
    Difference
    10%
    Check dated 2024-05-22T20:54:08.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:25:21.000Z thumbnail image

Stay in the know with updates to GB001 in Adult Subjects With Moderate to Severe Asthma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GB001 in Adult Subjects With Moderate to Severe Asthma Clinical Trial page.